Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
Jpn J Clin Oncol
; 41(3): 334-42, 2011 Mar.
Article
em En
| MEDLINE
| ID: mdl-21084436
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Radioterapia
/
Neoplasias Esofágicas
/
Protocolos de Quimioterapia Combinada Antineoplásica
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article